The document announces the 7th International Conference on Dementia and Care Practice to be held in Toronto, Canada from August 14-16, 2017. The conference will bring together over 400 participants from around the world to discuss the latest research on dementia diagnosis, treatment, and care practices through keynote lectures, oral presentations, symposiums and workshops. The main theme of the conference is "Discernment into innovative research and care practice approaches towards Dementia".

1. http://dementiacare.conferenceseries.com/
Toronto, Canada
August 14-16,2017
Dementia Care
2017
Dementia and Care Practice
7th
International Conference on
2
0
17
B
ro
c
h
u
re

2. Conference Series LLC welcomes you to attend the 7th
International Conference on
Dementia and Care Practice during August 14-16,2017 at Toronto, Canada.
We cordially invite all the participants who are interested in sharing their knowledge
and research in Dementia and Care Practice to navigate, discuss, inform and educate
themselves about this evolving Dementia and Care Practice landscape; to discuss the
latest research on Dementia and Care Practice diagnosis and treatment. Dementia and
Care Practice Congress -2017 anticipates more than 400 participants around the globe
with thought provoking Keynote lectures, Oral presentations, Symposiums, Workshops
and Poster presentations. The attending delegates include Editorial Board Members of
International Supporting Journals.
This is an excellent opportunity for the delegates from universities and institutes to
interact with the world class scientists and eminent personalities.
The intending participants can confirm their participation by registering for the
conference along with your colleagues. Avail the delegate Early Bird Offer.
The main theme of the conference is “Discernment into innovative research and
care practice approaches towards Dementia”.
Regards,
Dementia Care 2017
Organizing Committee
Invitation
Dementia Care
2017

3. International Supporting Journals
• 700 Open Access Journals
• 21 Day rapid review process
• 50000 Members Editorial team
• 25000 Reviewers team
• 3 Million Readers
• Publication within 7 days of acceptance
• Quality and quick editorial, review processing
Key features
• User friendly/feasible website translation of
your paper to 50 world’s leading languages
• Enhanced feature: Audio Version of published
paper
• Digital articles to share and explore
• Sharing Option: Social Networking Enabled
• Authors, Reviewers and Editors are provided
with Scientific Credits
Conference Series LLC Conferences
• 1000 Conferences all over the World in 2015
• Well organized scientific program
• Well known delegates and speakers across the
globe
Key features
• • Presentation by renowned speakers from all over
the world
• • Poster presentations and world class exhibits
• • Interactive Sessions
• • Platform for global networking
• • Connecting scientific community
Special Issues
All accepted abstracts will be published in respective international Journals
Each abstract will be provided with digital Object Identifier by
About Us
Dementia Care
2017

4. Dementia is the most common cause of death in women. Research on Dementia and Care Practice is
rapidlyprogressing,yetthesystematicapplicationofcurrentknowledgetoimprovepatientcareremainsa
formidable challenge. The significance can be gauged by the fact that it has made huge advancements over
the course of time and is continuing to influence various sectors in diagnosis and treatment of Dementia
and Care Practice.
Dementia Care 2017
• Opportunity to attend the presentations delivered by Eminent Personalities from all over the world
• Selected contributions will be published in following international Journals
• Journal of Alzheimers Disease and Parkinsonism
• Journal of Brain Disorders & Therapy
• Journal of Neurological Disorders
• Participation in sessions on specific topics on which the conference is expected to achieve progress
• Discuss and discover the latest research on Dementia and Care Practice
• Ongoing research related to the clinical management of Dementia and Care Practice
• Conference brings together Scientific Researchers, Medical, Surgical and Radiation Oncologists,
Pharmacists, fellows, Nurses, physician assistants, health care professionals Principal Investigators
and Business Entrepreneurs.
About Conference
Conference Highlights
Track 1: Dementia - Alzheimer’s and Vascular Dementia
Alzheimer’s is a kind of dementia that causes dilemma with memory, thinking and behaviour. This mainly happens
due to the disruptions caused in nerve cells within the brain. The brains of individuals with Alzheimer disease have
an abundance of 2 abnormal structures: amyloid plaques and neurofibrillary tangles that are product of misfolded
proteins. This can be very regular in certain regions of the brain that are necessary for memory. Another main
feature of Alzheimer’s disease is the loss of connections amidst cells. This results in diminished cell operate and
necrobiosis.
Track 2: Neurodegenerative Diseases
Neurodegenerative disease is an allied term for a range of conditions which primarily affect the neurons in the
brain and are incurable and attenuate conditions that dynamically result in degeneration or death of nerve cells.
Dementia Care
2017
Examples of neurodegenerative diseases include Dementia, Alzheimer’s,
Parkinson’s, amyotrophic lateral sclerosis and Huntington’s disease. The
most banal kind of neurodegenerative disorder which people are facing is
dementia.
Dementia is a group of conditions characterised by wreckage of at least
two brain functions, such as memory loss and judgment. The deficit
of brain function is stern enough that an individual cannot do normal
activities and leads to such an extent that it interferes with a person’s
lifestyle. Additionally, some individuals with dementia cannot manage

5. Dementia Care
2017
their emotions. The occurrence of dementia increases emblematically with increasing age. However, it’s not a standard part of
aging. Many people live into their 90s beyond with nil signs of dementia.
Track 3: Dementia Care Research
Amongst the induced and later stages of dementia an individual often involves challenging behavioural problems such as anger,
sadness, paranoia, confusion and fear that can further result in oppositional, aggressive and sometimes violent actions.
Although there is currently no cure for dementia and no way to stop the underlying death of brain cells, but dementia research
has shown that there is still a leeway to improve the essence of life of people living with dementia by providing a supportive
environment to them. An individual’s centred care is considered important which characterises a clear perceptive of the
individual and giving consideration to their cultural background, personal history, social and family networks and preferences for
activities in designing their care.
Track 4: Dementia Care Practice
Diagnosing dementia and Alzheimer is generally difficult, particularly in the initial stages. However diagnosis assessment
incorporates medical and patient history to rule out different possible causes. Therefore numerous diagnostic procedures
are needed which further includes neurological and physical examination related to blood and urine tests, Mental status
assessment to work out the level of mental deterioration, Brain scans (CT Scans and MRI), Caregiver interview to see the level of
dependency, Mini Mental State Examination (MMSE) can also be recommended.
Aside from these diagnostics, dementia patient needs reassurance and support from the people closest to them - including their
caregivers, friends and family to help the patient to reminisce their sense of existence and feelings of self-worth.
Track 5: Neurological Nursing
Neurological Nursing is a very provoking nursing specialty which deals with assessment, nursing diagnosis, and management of
many neurological disorders for which care practitioners provide patient care regarding neurological disorders such as trauma,
brain injuries, dementia, stroke, seizures, tumours, headaches, infections and aneurysms, as well as other neurological intricacies.
Talking about dementia, it encircles many different conditions and is apparent by a loss of cognitive abilities affecting
attention, memory, linguistics, reasoning and problem-solving skills that interfere with daily activities. It is caused by brain cell
deterioration.
Neurological care practitioners commit to give compassionate care to patients suffering from neurological diseases including
dementia and Alzheimer, from diagnosis to treatment and beyond.
Track 6: Person living with Dementia
Surviving with dementia from conditions such as Alzheimer’s and related disorders can have an ample of emotional, social,
psychological and practical impact on a person. Dementia sufferer finds that their mental abilities are declining, for instance,
difficulties to remember things, think clearly, communicate with others, or
take care of themselves and often feel vulnerable and need a great deal of
reassurance and support.
Track 7: Age and Dementia
Neurocognitive disorders accounts a class of mental state disorders that
essentially affect learning, memory, judgement, and cognitive behaviour,
dementia, and delirium. There’s no set age for these disorders to happen but
it has been found that age-associated memory impairment and dementia
increases typically with increasing age. Geriatrics scrutinised and stated that
people facing dementia whose symptoms started before the age of 65 are often

6. Dementia Care
2017
considered as ‘younger people with dementia’ or as having young-onset dementia and those before the age of 65 are consider
under “early onset dementia or “working age dementia” category.
Track 8: Factors influence Dementia
Dementia is the case that people over 60 fear the most. The most common factors which enhances the risk of developing
dementia includes ageing, accumulation of ApoE, Alcohol use, Genetics, Down syndrome, Atherosclerosis, Depression, stroke,
Diabetes, Hypertension, Mental illness, smoking, Unhealthy diet, Head injuries and many more.
There is no proper cure for dementia; yet medication (including cholinesterase inhibitors containing Donepezil-Rex) and non-drug
treatments could give some comfort. However, dementia is not inexorable as we age and there is a lot we can do to dwindle the
chances of mellowing it.
Track 9: Diagnosis and Prognosis of Dementia
Dementia is not a disease; it’s actually a comprehensive term that portrays a wide range of symptoms related with a drop in
memory or thinking skills severe enough to turn down a person’s aptitude to perform everyday activities.
No single test can disclose if someone is demented or not however, Doctors or physicians can almost rules out if a person has
dementia using medical evaluations which comprises of medical history, mental status testing (Mini-mental state examination,
Mini-Cog test) , physical and neurological exams, blood tests and brain imaging (CT Scans and MRI).Though treatment for
dementia is entering an energising stage, following many new medications depending upon the pathogenesis of Alzheimer’s
illness.
Track 10: Animal Models and Translational Medicine
Dementia is a syndrome with eccentric memory loss and impaired ability to recall events from the past often characterized by
Alzheimer’s disease. Animal models for dementia or Alzheimer is important to think about the human phenotype and what is
being modelled in terms of the animal phenotype. Animal models of Alzheimer’s disease or dementia, based on the genetics of the
disease and the closely related front temporal dementia, replicate at least some of the pathology.
Researchers have been successful at modelling very specific aspects of Alzheimer in the mouse for instance plaques, tangles.
Multiple approaches have been adopted to create reliable animal models ranging from rodents to non-human primates, where
the animals are exposed to a predetermined injury or causing genetic ablation across specific regions of brain suspected to affect
learning functions.
Track 11: Biomarkers in Dementia
Experts believe that biomarkers offer most promising paths to diagnose Alzheimer’s or dementia. A biomarker is something that
can reliably indicate the presence of disease.
Certain possible biomarkers are being studied for their strength to indicate
initial stages of Dementia or Alzheimer’s disease such as including beta-
amyloid and tau levels in cerebrospinal fluid (CSF) and brain changes
detectable by imaging. However, three biomarkers have been well-established
and validated internationally to diagnose AD in CSF with ELISAs: β-amyloid
(1–42) [Aβ (1–42)], total tau and phospho-tau-181
Track 12: Amyloid Protein in Dementia
All cells are like minute factories, producing thousands of proteins with precise
functions to keep the cells viable. A flaw can occur if a protein is altered, or
if excess or too little is formed. Sometimes, the consequences are so severe
that a cell dies. Neuron ruination is the chief cause of dementia and is often

7. Dementia Care
2017
associated to malfunctions in the connection system that a neuron needs to survive.
Dementia is associated with accumulation of two proteins – amyloid and tau - into plaques and tangles in the brain. Beta-
amyloid accumulates as plaques in Alzheimer’s disease or dementia and is an endorsement of the disease. Tau compiles into
tangles (known as neurofibrillary tangles or NFT). And further disrupts the structure and communication within the nerve cells,
leading to cell death.
Track 13: Neuropathology
Dementia is among the most typical neurodegenerative diseases which specifically arise due to neuron death. It is now becoming
evident that neurodegenerative diseases have a biochemical basis. Many neurodegenerative diseases are inherited. Their genes
are known and DNA-based diagnosis (including prenatal diagnosis) is available. Loss of neurons is accompanied by specific
histopathological findings such as Alzheimer’s plaques and Lewy bodies. Some neurodegenerative diseases engage specific
anatomical systems or adjoining sets of neurons.
Track 14: Neuropharmacology
Dementia is a common clinical phenomenon; however, management of the coexisting illnesses remains incomplete.
Neuropsychiatric turmoil is one of the clinical characteristics of Dementia. Traditionally, this turmoil has been managed with
neuroleptics or benzodiazepines but accounts serious side effects. With the advancement in the neuropharmacology field, many
new-fangled medications came into existence. Donepezil is a piper dine based reversible, non-competitive cholinesterase inhibitor
and proved beneficial for the management of symptoms of Alzheimer’s disease covering dementia, a disease in which cholinergic
pathways in the cerebral cortex and basal forebrain are well known to be compromised.
Track 15: Therapeutic Approaches towards Dementia
There are a numerous ways to categorise interventions in dementia care, for instance, by the kind of treatment approach used.
The chief grouping is by the therapeutic goal, with three considerable spheres recommended: the maintenance of function,
including cognitive functions, the management of behaviours that challenge and the reduction of comorbid emotional disorders.
The range of non-pharmacological ‘interventions’ in dementia care is ample and would include the everyday interactions of carers
with the person suffering from dementia, the effect of the physical and social conditions and all manner of ‘therapies’, ranging
from art sessions to contact with animals.

8. Toronto is the provincial capital of Ontario covering an area of 630 square kilometres due north-south stretch of 21
kilometres and east-west stretch of 43 km. It is an alluring, safest metropolitan area with a wonderful chain of parks,
recreational, and cultural efficiencies. Toronto is the home of six major league sports and amongst largest English-speaking
theatre district over the world, behind New York and London. One of the world’s most ethnically diverse cities, it is cottage
to nearly 80 ethnic communities from Africa, Asia, and Europe. It serves as the business centre of Canada.
TorontohasampleofacademicinstitutionsholdingCanada’slargestUniversity,TheUniversityofToronto,established
in 1827. Moreover it is home to around 20 public hospitals. It also hosts vast variety of health-focused non- profit
organisations. Canada ranks fourth position in the world for its scientific research.
AboutToronto,Canada
Important Dates
Abstract submission opens: September 15, 2016
Registration opens: September 04, 2016
Early bird registration: December 28, 2016
On spot registration: August 14, 2017
Venue
Toronto, Canada
August 14-16,2017
Dementia Care
2017

9. City Attractions of Toronto
canada-toronto-st-lawrence-market
canada-toronto-cn-tower
canada-toronto-high-park canada-toronto-royal-ontario-museumcanada-toronto-ontario-science-center
canada-toronto-eaton-center-interior-shops canada-toronto-entertainment-district
canada-toronto-casa-loma canada-toronto-city-hall
Conference Secretariat
2360 Corporate Circle. Suite 400, Henderson, NV 89074-7722, USA
Tel: +1-888-843-8169, Fax: +1-650-618-1417
Email: : dementiacare@neuroconferences.com
Dementia Care
2017